27 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
to the American Motility Society Task Force on Gastroparesis, the prevalence of gastroparesis is estimated to be up to 4% of the United States … to the American Motility Society Task Force on Gastroparesis, up to 4% of the U.S. population experiences symptomatic manifestations of gastroparesis
424B4
EVOK
Evoke Pharma Inc
9 Feb 24
Prospectus supplement with pricing info
5:14pm
, no cause can be identified, which is referred to as idiopathic gastroparesis. According to the American Motility Society Task Force on Gastroparesis
8-K
EX-99.1
rtn3juhuj m05ry8y
9 Nov 23
Evoke Pharma Reports Third Quarter 2023 Financial Results
9:00am
8-K
EX-99.1
z6iqcsw3ff9ss zfcn
10 Aug 23
Evoke Pharma Reports Second Quarter 2023 Financial Results
9:03am
424B5
k86z d7wibun06
22 Jul 16
Prospectus supplement for primary offering
12:00am